106,548 Shares in SPDR S&P Biotech ETF $XBI Acquired by Riggs Asset Managment Co. Inc.

Riggs Asset Managment Co. Inc. purchased a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 106,548 shares of the exchange traded fund’s stock, valued at approximately $12,991,000. SPDR S&P Biotech ETF makes up approximately 2.6% of Riggs Asset Managment Co. Inc.’s investment portfolio, making the stock its 9th biggest holding. Riggs Asset Managment Co. Inc. owned about 0.16% of SPDR S&P Biotech ETF as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in XBI. Davis Capital Management purchased a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter worth approximately $35,000. Halbert Hargrove Global Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at $40,000. Barnes Dennig Private Wealth Management LLC acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth $48,000. Premier Financial Group acquired a new stake in SPDR S&P Biotech ETF during the 3rd quarter worth $50,000. Finally, MMA Asset Management LLC purchased a new stake in SPDR S&P Biotech ETF in the third quarter valued at $59,000.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $134.49 on Friday. SPDR S&P Biotech ETF has a 1-year low of $75.68 and a 1-year high of $139.19. The stock has a market cap of $8.73 billion, a PE ratio of 11.47 and a beta of 0.88. The firm has a fifty day moving average price of $127.28 and a 200 day moving average price of $121.69.

SPDR S&P Biotech ETF Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.

See Also

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.